Moderna on booster race: May the best data win

The booster competition is on, and new faces not present when the first Covid-19 vaccines were developed are joining in. Even so, Moderna has a card up its sleeve, according to Head of Europe Dan Staner.


Moderna’s head in Europe, Dan Staner, has noticed a rise in competitors vying for the European booster market.

One week ago, Novavax’s best bid for a Covid-19 was approved in the US. Sanofi/GSK and Bavarian Nordic are also working on vaccines against the virus.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Sanofi reduces US insulin prices for the uninsured

While bills to introduce a price cap on insulin are being discussed in the US Senate, Sanofi has beaten them to the punch and reduced the price of insulin products for US diabetes patients without insurance.

Further reading

Related articles

Latest news

See all jobs